1-12 of 12
Dirk Müller-Wieland
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

807-P: Glycemic Control in People with Type 2 Diabetes (PWT2D) Switching from NPH to Insulin Glargine 300 U/mL (Gla-300) : REALI Pooled Database

DIRK MÜLLER-WIELAND, NICK FREEMANTLE, RICCARDO C. BONADONNA, CELINE MAUQUOI, GREGORY BIGOT, MIREILLE BONNEMAIRE, PIERRE GOURDY, DIDAC MAURICIO
Journal: Diabetes
Diabetes 2022;71(Supplement_1):807-P
DOI: https://doi.org/10.2337/db22-807-P
Published: 01 June 2022
View article
Meeting Abstracts

724-P: Factors Associated with Glycemic Control in People with Type 1 Diabetes (PWT1D) Switched to Once Daily (QD) Insulin Glargine (Gla) 300 U/mL (Gla-300): The European REALI Pooled Database

DIRK MÜLLER-WIELAND, PIERRE GOURDY, RICCARDO C. BONADONNA, NICK FREEMANTLE, GREGORY BIGOT, CORINNE JAMOUL, ALICE CIOCCA, MIREILLE BONNEMAIRE, DIDAC MAURICIO
Journal: Diabetes
Diabetes 2021;70(Supplement_1):724-P
DOI: https://doi.org/10.2337/db21-724-P
Published: 01 June 2021
View article
Meeting Abstracts

581-P: Remnant Cholesterol: Association to Components of the Metabolic Syndrome or Triglyceride-Glucose Index in the LUPS Cohort

JULIA BRANDTS, BIRGIT KNEBEL, JORG KOTZKA, KATHARINA SCHUETT, NIKOLAUS MARX, KAUSIK K. RAY, DIRK MÜLLER-WIELAND, LUPS CONSORTIUM
Journal: Diabetes
Diabetes 2020;69(Supplement_1):581-P
DOI: https://doi.org/10.2337/db20-581-P
Published: 01 June 2020
View article
Meeting Abstracts

1109-P: Type 2 Diabetes Treatment in Patients with Chronic Kidney Disease: Efficacy and Safety of Initiating Insulin Glargine 300 U/mL—REALI Pooled Data Analysis

DIDAC MAURICIO, PIERRE GOURDY, RICCARDO C. BONADONNA, NICK FREEMANTLE, GREGORY BIGOT, CELINE MAUQUOI, ALICE CIOCCA, MIREILLE BONNEMAIRE, DIRK MÜLLER-WIELAND
Journal: Diabetes
Diabetes 2019;68(Supplement_1):1109-P
DOI: https://doi.org/10.2337/db19-1109-P
Published: 01 June 2019
View article
Meeting Abstracts

1097-P: Glycemic Control and Safety Profile of Insulin Glargine 300 U/mL in Older Adults—REALI Pooled Data Analysis

RICCARDO C. BONADONNA, DIDAC MAURICIO, DIRK MÜLLER-WIELAND, NICK FREEMANTLE, GREGORY BIGOT, CELINE MAUQUOI, ALICE CIOCCA, MIREILLE BONNEMAIRE, PIERRE GOURDY
Journal: Diabetes
Diabetes 2019;68(Supplement_1):1097-P
DOI: https://doi.org/10.2337/db19-1097-P
Published: 01 June 2019
View article
Meeting Abstracts

2323-PUB: Predictive Factors of Clinically Important HbA1c Improvement in People with T2DM Initiating Treatment with Insulin Glargine 300 U/mL (Gla-300)—Multivariable Analysis from REALI Pooled Database

GREGORY BIGOT, MIREILLE BONNEMAIRE, RICCARDO C. BONADONNA, PIERRE GOURDY, DIRK MÜLLER-WIELAND, DIDAC MAURICIO, ALICE CIOCCA, NICK FREEMANTLE
Journal: Diabetes
Diabetes 2019;68(Supplement_1):2323-PUB
DOI: https://doi.org/10.2337/db19-2323-PUB
Published: 01 June 2019
View article
Meeting Abstracts

2328-PUB: Identification by Multivariable Analysis of Predictive Factors of HbA1c Target Achievement in People with T2D Initiating Treatment with Insulin Glargine 300 U/mL (Gla-300)—REALI Pooled Database

NICK FREEMANTLE, GREGORY BIGOT, MIREILLE BONNEMAIRE, DIDAC MAURICIO, RICCARDO C. BONADONNA, PIERRE GOURDY, ALICE CIOCCA, DIRK MÜLLER-WIELAND
Journal: Diabetes
Diabetes 2019;68(Supplement_1):2328-PUB
DOI: https://doi.org/10.2337/db19-2328-PUB
Published: 01 June 2019
View article
Meeting Abstracts

146-OR: Differences in HbA1c-Lowering Effect and Hypoglycemia Risk between Gla-300 and IDeg According to Renal Function in the BRIGHT Trial

MARTIN HALUZIK, ATHENA PHILIS-TSIMIKAS, ZSOLT BOSNYAK, DIRK MÜLLER-WIELAND, FELIPE LAUAND, SR., LYDIE MELAS-MELT, JULIO ROSENSTOCK, GEREMIA B. BOLLI
Journal: Diabetes
Diabetes 2019;68(Supplement_1):146-OR
DOI: https://doi.org/10.2337/db19-146-OR
Published: 01 June 2019
View article
Meeting Abstracts

175-OR: Effect of Alirocumab in Individuals with Type 2 Diabetes and High Triglycerides and Low High-Density Lipoprotein Cholesterol

HELEN M. COLHOUN, LAWRENCE A. LEITER, DIRK MÜLLER-WIELAND, BERTRAND CARIOU, KAUSIK K. RAY, FRANCISCO TINAHONES, CATHERINE DOMENGER, ALEXIA LETIERCE, MARC ISRAEL, STEFANO DEL PRATO
Journal: Diabetes
Diabetes 2019;68(Supplement_1):175-OR
DOI: https://doi.org/10.2337/db19-175-OR
Published: 01 June 2019
View article
Journal Articles

Insulin Resistance and Vulnerability to Cardiac Ischemia

Tomas Jelenik, Ulrich Flögel, Elisa Álvarez-Hernández, Daniel Scheiber, Elric Zweck, Zhaoping Ding, Maik Rothe, Lucia Mastrototaro, Vivien Kohlhaas, Jörg Kotzka, Birgit Knebel, Dirk Müller-Wieland, Sarah Moellendorf, Axel Gödecke, Malte Kelm, Ralf Westenfeld, Michael Roden, Julia Szendroedi
Journal: Diabetes
Diabetes 2018;67(12):2695–2702
DOI: https://doi.org/10.2337/db18-0449
Published: 26 September 2018
View article
PDF
Includes: Supplementary data
Journal Articles

Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver

Tomas Jelenik, Kirti Kaul, Gilles Séquaris, Ulrich Flögel, Esther Phielix, Jörg Kotzka, Birgit Knebel, Pia Fahlbusch, Tina Hörbelt, Stefan Lehr, Anna Lena Reinbeck, Dirk Müller-Wieland, Irene Esposito, Gerald I. Shulman, Julia Szendroedi, Michael Roden
Journal: Diabetes
Diabetes 2017;66(8):2241–2253
DOI: https://doi.org/10.2337/db16-1147
Published: 10 May 2017
View article
PDF
Includes: Supplementary data
Journal Articles

Insulin-Receptor Gene and Its Expression in Patients With Insulin Resistance

Dirk Muller-Wieland, Rebecca Taub, Dinesh S Tewari, Kristina M Kriaciunas, S Sethu, K Reddy, C Ronald Kahn
Journal: Diabetes
Diabetes 1989;38(1):31–38
DOI: https://doi.org/10.2337/diab.38.1.31
Published: 01 January 1989
View article
PDF